Home > Insider Trading > Filing (0001179110-14-017218)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274057	Hospira Inc	HSP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1617306	J Marc Yoskowitz	C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045	Svp, Strategy & Corporate Dev	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-25	11,523	$37.36	43,146	No	4	M	Direct
Common Stock	Disposition	2014-11-25	11,523	$59.93	31,623	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Acquisiton	2014-11-25	11,523	$0.00	11,523	$37.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,570		2020-06-28	No	4	M	Direct

Footnotes

Exercise of derivative security exempted pursuant to Rule 16b-3.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $59.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
The stock options, granted on June 28, 2013, vest in four equal annual installments on June 28, 2014, 2015, 2016, and 2017. The exercise price of $37.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on June 28, 2020.